LABT Stock Chart & Stats
$2.64
-$0.14(-5.30%)
At close: 4:00 PM EDT
$2.64
-$0.14(-5.30%)
Day’s Range― - ―
52-Week Range$1.66 - $98.20
Previous Close$2.46
Volume297.45K
Average Volume (3M)3.31M
Market Cap
$4.38M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-4.00
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding1,750,789
10 Day Avg. Volume315,631
30 Day Avg. Volume3,307,854
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap0.00
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Lakewood-Amedex Biotherapeutics Inc. News
LABT FAQ
What was Lakewood-Amedex Biotherapeutics Inc.’s price range in the past 12 months?
Lakewood-Amedex Biotherapeutics Inc. lowest stock price was $1.66 and its highest was $98.20 in the past 12 months.
What is Lakewood-Amedex Biotherapeutics Inc.’s market cap?
Lakewood-Amedex Biotherapeutics Inc.’s market cap is $4.38M.
When is Lakewood-Amedex Biotherapeutics Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Lakewood-Amedex Biotherapeutics Inc.’s earnings last quarter?
Currently, no data Available
Is Lakewood-Amedex Biotherapeutics Inc. overvalued?
According to Wall Street analysts Lakewood-Amedex Biotherapeutics Inc.’s price is currently Overvalued.
Does Lakewood-Amedex Biotherapeutics Inc. pay dividends?
Lakewood-Amedex Biotherapeutics Inc. does not currently pay dividends.
What is Lakewood-Amedex Biotherapeutics Inc.’s EPS estimate?
Lakewood-Amedex Biotherapeutics Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Lakewood-Amedex Biotherapeutics Inc. have?
Lakewood-Amedex Biotherapeutics Inc. has 1,750,789 shares outstanding.
What happened to Lakewood-Amedex Biotherapeutics Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Lakewood-Amedex Biotherapeutics Inc.?
Currently, no hedge funds are holding shares in LABT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Lakewood-Amedex Biotherapeutics Inc.
This biopharmaceutical company is dedicated to developing innovative antimicrobial therapies. Its array of anti-infective products is designed to tackle specific viral conditions, including avian influenza, Epstein-Barr Virus (EBV), and hepatitis B and C. Established by Roderic Dale on July 11, 2006, the firm maintains its principal office in Bradenton, Florida.
AIM ImmunoTech
―
Kiora Pharmaceuticals
―
PharmaCyte Biotech
―
BioRestorative Therapies
―
Chemomab Therapeutics
―